Filter posts

The Right Way to Address Prescription Drug Costs

Writing for STAT News, BIO’s President and CEO Jim Greenwood teamed up with Bay City …

ICYMI: Making Biopharmaceutical Innovation a Priority of the Next Administration

Last week, Astellas Americas President Jim Robinson wrote an op-ed in Forbes exploring, “How The …

A Rehash Of Tired, Old Ideas From President Obama

Many of the biopharmaceutical policy proposals laid out by President Obama in his JAMA article …